Attention Deficit Disorder With Hyperactivity
Conditions
Keywords
Behavior Therapy, Cognitive Therapy, Adolescents, Psychotherapy, Group
Brief summary
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder which starts in childhood and is characterized by symptoms of attention deficit, hyperactivity and impulsivity. Persistence into adolescence is frequently associated with among other low educational achievement, interpersonal difficulties, anxious and depressive symptoms and sleep problems. Treatment guidelines recommend psychological treatment as part of the treatment plan, however compared to children and adults, there is still a substantial lack of knowledge about appropriate psychological treatment in adolescents. The present study examines a psychological intervention for adolescents with ADHD, cognitive behavior group therapy. The intervention consists of 12 weekly cognitive behavioral therapy sessions addressing core difficulties and concerns of the adolescent population with ADHD. The investigators wish to determine the efficacy of group therapy in adolescents with ADHD who receive medical treatment but still have impairing ADHD symptoms.
Detailed description
Change February 1st 2017: Inclusion of patients with mild to moderate behavioral problems in order to achieve enough participants in the study. Change February 1st 2017: The study primarily recruits patients who are on pharmacological treatment for ADHD. However, for ethical reasons and in order to achieve enough participants, the study will also recruit patients who have not responded to at least two drug trials or have been unable to continue pharmacological treatment because of intolerable side effects. Change February 1st 2018: The Weiss Functional Impairment Rating Scale, Rosenberg and BRIEF questionnaires will not be collected at the 9-month follow-up due to lack of resources (project assistance).
Interventions
BEHAVIORALcognitive behavior group therapy
1,5 hours weekly session during 12 weeks, 8 participants, 2 therapists.
OTHERTreatment as usual
Education on ADHD, and ADHD medication if indicated
Sponsors
Norwegian University of Science and Technology
St. Olavs Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
14 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* Attention deficit hyperactivity disorder (ICD-10) * Clinical Global Impression (CGI) \>=3 * Informed consent patient * informed consent parents * if on medication, dosage is stable since at least 2 months
Exclusion criteria
* mental retardation * behavioral problems * drug addiction * psychosis * suicidal
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ADHD-Rating Scale (ADHD-RS) | 12 weeks (at baseline and immediately after the last group therapy session) | interview |
Secondary
| Measure | Time frame |
|---|---|
| Clinical Global Impression (CGI) | 12 weeks (at baseline and immediately after the last group therapy session) |
| Weiss Functional Impairment Rating Scale (WFIRS) | 12 weeks (at baseline and immediately after the last group therapy session) |
| Children's Global Assessment Scale (CGAS) | 9 months |
| Anxiety symptoms (SCARED) | 12 weeks (at baseline and immediately after the last group therapy session) |
| Depressive symptoms (Mood and Feelings Questionnaire (MFQ) Norwegian version Humøret ditt) | 12 weeks (at baseline and immediately after the last group therapy session) |
| ADHD-Rating Scale (ADHD-RS) | 9 months |
| Self-esteem (Rosenberg Self-Esteem Scale) | 12 weeks (at baseline and immediately after the last group therapy session) |
| Self-efficacy (General Perceived Self-Efficacy Scale) | 12 weeks (at baseline and immediately after the last group therapy session) |
| Executive functioning (Behavior Rating Scale of Executive Functioning, BRIEF) | 12 weeks (at baseline and immediately after the last group therapy session) |
| ASEBA Brief Problem Monitor | 9 months |
| Sleep problems (Adolescent Sleep Wake Scale | 12 weeks (at baseline and immediately after the last group therapy session) |
Countries
Norway
Outcome results
None listed